<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Oral Cancer News &#187; cervical cancer</title>
	<atom:link href="http://oralcancernews.org/wp/tag/cervical-cancer/feed/" rel="self" type="application/rss+xml" />
	<link>http://oralcancernews.org/wp</link>
	<description>The Oral Cancer Foundation News Archive</description>
	<lastBuildDate>Mon, 06 Feb 2012 22:09:34 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Success of HPV vaccination is now a matter of coverage</title>
		<link>http://oralcancernews.org/wp/success-of-hpv-vaccination-is-now-a-matter-of-coverage/</link>
		<comments>http://oralcancernews.org/wp/success-of-hpv-vaccination-is-now-a-matter-of-coverage/#comments</comments>
		<pubDate>Wed, 04 Jan 2012 20:12:01 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[cervical cancer]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[genital warts]]></category>
		<category><![CDATA[GlaxoSmithKline]]></category>
		<category><![CDATA[hpv vaccine]]></category>
		<category><![CDATA[oropharyngeal cancer]]></category>
		<category><![CDATA[precancers]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12261</guid>
		<description><![CDATA[Source: The Lancet Oncology, Volume 13, Issue 1, Pages 10-12, January 2012 In a pair of articles in The Lancet Oncology, Lehtinen and colleagues and Wheeler and colleagues present 4-year end of study data from a trial of a prophylactic human papillomavirus (HPV)-16/-18 vaccine (Cervarix, GlaxoSmithKline) in young women aged 15-25 years. From a public-health [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/success-of-hpv-vaccination-is-now-a-matter-of-coverage/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Preventing Cancer with Vaccines: Progress in the Global Control of Cancer</title>
		<link>http://oralcancernews.org/wp/preventing-cancer-with-vaccines-progress-in-the-global-control-of-cancer/</link>
		<comments>http://oralcancernews.org/wp/preventing-cancer-with-vaccines-progress-in-the-global-control-of-cancer/#comments</comments>
		<pubDate>Wed, 04 Jan 2012 17:18:40 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[cervical cancer]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[oropharyngeal cancer]]></category>
		<category><![CDATA[vaccines]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12259</guid>
		<description><![CDATA[Source: CancerPreventionResearch.AACJournals.org Abstract The cancer control community is largely unaware of great advances in the control of major human cancers with vaccines, including the dramatic control of hepatocellular (liver) cancer with hepatitis B virus (HBV) vaccine, now used routinely in more than 90% of countries. The biotechnology revolution has given us a new generation of [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/preventing-cancer-with-vaccines-progress-in-the-global-control-of-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Study Endorses HPV Testing for All Women Over 30</title>
		<link>http://oralcancernews.org/wp/study-endorses-hpv-testing-for-all-women-over-30/</link>
		<comments>http://oralcancernews.org/wp/study-endorses-hpv-testing-for-all-women-over-30/#comments</comments>
		<pubDate>Tue, 27 Dec 2011 18:06:49 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[cervical cancer]]></category>
		<category><![CDATA[DNA test]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[National Cancer Institute]]></category>
		<category><![CDATA[Pap smear]]></category>
		<category><![CDATA[pre-cancerous lesions]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12230</guid>
		<description><![CDATA[Source: Medscape.com LONDON (Reuters) Dec 15 &#8211; New DNA tests looking for the virus responsible for most cases of cervical cancer make sense for all women aged 30 or over, since they can prevent more cases of cancer than Pap smears alone, Dutch researchers say. Results of a five-year study involving 45,000 women provided the [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/study-endorses-hpv-testing-for-all-women-over-30/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>UI professors: HPV editorial misses the mark</title>
		<link>http://oralcancernews.org/wp/ui-professors-hpv-editorial-misses-the-mark/</link>
		<comments>http://oralcancernews.org/wp/ui-professors-hpv-editorial-misses-the-mark/#comments</comments>
		<pubDate>Thu, 08 Dec 2011 17:31:17 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[CDC]]></category>
		<category><![CDATA[cervical cancer]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[HPV vaccines]]></category>
		<category><![CDATA[Pap smears]]></category>
		<category><![CDATA[radiation]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12177</guid>
		<description><![CDATA[Source: The Daily Iowan The Nov. 29 editorial &#8220;Recommend Pap smears, not vaccines, to prevent cervical cancer&#8221; completely missed the mark with regard to HPV vaccines. We are researchers and clinicians at the University of Iowa who study and treat HPV and other infectious diseases. It is disturbing to think that the article might dissuade [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/ui-professors-hpv-editorial-misses-the-mark/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>HPV vaccine myths put health, lives at risk, say health leaders: Airing the facts</title>
		<link>http://oralcancernews.org/wp/hpv-vaccine-myths-put-health-lives-at-risk-say-health-leaders-airing-the-facts/</link>
		<comments>http://oralcancernews.org/wp/hpv-vaccine-myths-put-health-lives-at-risk-say-health-leaders-airing-the-facts/#comments</comments>
		<pubDate>Thu, 01 Dec 2011 19:40:20 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Centers for Disease Control and Prevention]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[cervical cancer]]></category>
		<category><![CDATA[Food and Drug Administration]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[human papillomavirus]]></category>
		<category><![CDATA[journal of the national cancer institute]]></category>
		<category><![CDATA[Kaiser Family Foundation]]></category>
		<category><![CDATA[vaccination]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12152</guid>
		<description><![CDATA[Source: TheNationsHealth.org Vaccination rates for human papillomavirus are lagging for teens, and a complicated web of confusion and misinformation may be to blame, according to public health leaders. Several strains of HPV can cause cervical cancer, and two vaccines, Gardasil and Cervarix, have been shown conclusively to defend against those strains. The Food and Drug [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/hpv-vaccine-myths-put-health-lives-at-risk-say-health-leaders-airing-the-facts/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Use and Acceptance of HPV Vaccine Still a Work in Progress</title>
		<link>http://oralcancernews.org/wp/use-and-acceptance-of-hpv-vaccine-still-a-work-in-progress/</link>
		<comments>http://oralcancernews.org/wp/use-and-acceptance-of-hpv-vaccine-still-a-work-in-progress/#comments</comments>
		<pubDate>Wed, 30 Nov 2011 17:44:27 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Advisory Committee on Immunization Practices]]></category>
		<category><![CDATA[anal cancer]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[CDC]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[cervical cancer]]></category>
		<category><![CDATA[Division of Cancer Control and Population Sciences]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[genital warts]]></category>
		<category><![CDATA[HPV 18]]></category>
		<category><![CDATA[HPV-16]]></category>
		<category><![CDATA[NCI]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12139</guid>
		<description><![CDATA[Source: National Cancer Institute A bellwether moment in the history of cancer prevention came in 2006 when the Food and Drug Administration (FDA) approved the first vaccine to prevent cervical cancer. The vaccine, Gardasil, protects against the two primary cancer-causing, or oncogenic, types of the human papillomavirus (HPV)—HPV-16 and HPV-18. These types are responsible for [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/use-and-acceptance-of-hpv-vaccine-still-a-work-in-progress/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Trial Confirms Efficacy of HPV Vaccine, Shows Cross-Protection</title>
		<link>http://oralcancernews.org/wp/trial-confirms-efficacy-of-hpv-vaccine-shows-cross-protection/</link>
		<comments>http://oralcancernews.org/wp/trial-confirms-efficacy-of-hpv-vaccine-shows-cross-protection/#comments</comments>
		<pubDate>Wed, 30 Nov 2011 01:53:57 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[cervical cancer]]></category>
		<category><![CDATA[hepatitis A]]></category>
		<category><![CDATA[HPV 18]]></category>
		<category><![CDATA[HPV-16]]></category>
		<category><![CDATA[Papilloma Trial against Cancer in Young Adults]]></category>
		<category><![CDATA[vaccination]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12136</guid>
		<description><![CDATA[Source: National Cancer Institute End-of-trial results from a trial testing Cervarix, a vaccine against human papillomavirus (HPV) types 16 and 18, showed that the vaccine continued to provide substantial protection against cervical precancers 4 years after vaccination. Cervarix provided almost complete protection in young women who had no evidence of exposure to HPV at the [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/trial-confirms-efficacy-of-hpv-vaccine-shows-cross-protection/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Data Published in the Lancet Oncology Support High Efficacy Previously Demonstrated By Cervarix</title>
		<link>http://oralcancernews.org/wp/data-published-in-the-lancet-oncology-support-high-efficacy-previously-demonstrated-by-cervarix/</link>
		<comments>http://oralcancernews.org/wp/data-published-in-the-lancet-oncology-support-high-efficacy-previously-demonstrated-by-cervarix/#comments</comments>
		<pubDate>Wed, 16 Nov 2011 19:04:02 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[cervical cancer]]></category>
		<category><![CDATA[GlaxoSmithKline]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[hpv vaccine]]></category>
		<category><![CDATA[Lancet Oncology]]></category>
		<category><![CDATA[oral cancer]]></category>
		<category><![CDATA[oral cancer foundation]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12074</guid>
		<description><![CDATA[Source: Therapeutics Daily Author: Staff LONDON, Nov. 9, 2011-An analysis published today in The Lancet Oncology reinforces previous findings showing that GlaxoSmithKline’s Cervarix®, provided protection against advanced precancerous lesions (CIN3+), above that expected from a vaccine that protects against human papillomavirus (HPV) types 16 and 18. CIN3+ is the immediate step before invasive cervical cancer and data showing protection [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/data-published-in-the-lancet-oncology-support-high-efficacy-previously-demonstrated-by-cervarix/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Implications of the Oropharyngeal Cancer Epidemic</title>
		<link>http://oralcancernews.org/wp/implications-of-the-oropharyngeal-cancer-epidemic/</link>
		<comments>http://oralcancernews.org/wp/implications-of-the-oropharyngeal-cancer-epidemic/#comments</comments>
		<pubDate>Wed, 09 Nov 2011 22:24:59 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[anal cancer]]></category>
		<category><![CDATA[Centers for Disease Control and Prevention]]></category>
		<category><![CDATA[cervical cancer]]></category>
		<category><![CDATA[chemoradiotherapy]]></category>
		<category><![CDATA[genital warts]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[oncologists]]></category>
		<category><![CDATA[oropharyngeal squamous cell carcinoma]]></category>
		<category><![CDATA[radiotherapy]]></category>
		<category><![CDATA[Residual Tissues Repositories Program]]></category>
		<category><![CDATA[SEER]]></category>
		<category><![CDATA[US Food and Drug Administration]]></category>
		<category><![CDATA[vaccination]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12061</guid>
		<description><![CDATA[Source: Journal of Clinical Oncology Chaturvedi et al,1 analyzing specimens back to 1984, validate the long-held hypothesis that infection with human papillomavirus (HPV) has increased oropharyngeal squamous cell carcinoma (OPSCC) incidence in the US. They find the incidence of OPSCC in men—who have higher risks of both HPV-positive and HPV-negative OPSCC than women—similar to that [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/implications-of-the-oropharyngeal-cancer-epidemic/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HPV Vaccination Could Reduce the Number of Screening Procedures</title>
		<link>http://oralcancernews.org/wp/hpv-vaccination-could-reduce-the-number-of-screening-procedures/</link>
		<comments>http://oralcancernews.org/wp/hpv-vaccination-could-reduce-the-number-of-screening-procedures/#comments</comments>
		<pubDate>Wed, 09 Nov 2011 03:45:02 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[cervical cancer]]></category>
		<category><![CDATA[GlaxoSmithKline]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[vaccination]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12047</guid>
		<description><![CDATA[The National Journal By Sophie Quinton Widespread vaccination against cervical cancer could reduce the need for burdensome screenings, U.S. and Finnish researchers said on Tuesday. A study published in the journal Lancet Oncology show that GlaxoSmithKline’s Cervarix vaccine, which protects against two strains of human papillomavirus, or HPV, was more than 93 percent effective in [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/hpv-vaccination-could-reduce-the-number-of-screening-procedures/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Possible Link Between HPV and Heart Disease</title>
		<link>http://oralcancernews.org/wp/possible-link-between-hpv-and-heart-disease/</link>
		<comments>http://oralcancernews.org/wp/possible-link-between-hpv-and-heart-disease/#comments</comments>
		<pubDate>Wed, 26 Oct 2011 17:59:28 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[cervical cancer]]></category>
		<category><![CDATA[heart disease]]></category>
		<category><![CDATA[high blood pressure]]></category>
		<category><![CDATA[high cholesterol]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[Journal of the American College of Cardiology]]></category>
		<category><![CDATA[p53]]></category>
		<category><![CDATA[retinoblastoma protein]]></category>
		<category><![CDATA[stroke]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11971</guid>
		<description><![CDATA[Source: CVTNews.ca We already know HPV, or human papillomavirus, can cause cervical cancer. It&#8217;s also known to cause some kinds of oral cancer. But could HPV also cause heart disease? An intriguing new study is drawing a link. The study found that women who are known to be infected with cancer-causing strains of the virus may [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/possible-link-between-hpv-and-heart-disease/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HPV Vaccine Recommended for Boys aged 11 to 12 Years</title>
		<link>http://oralcancernews.org/wp/hpv-vaccine-recommended-for-boys-aged-11-to-12-years/</link>
		<comments>http://oralcancernews.org/wp/hpv-vaccine-recommended-for-boys-aged-11-to-12-years/#comments</comments>
		<pubDate>Wed, 26 Oct 2011 17:31:59 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[anal cancer]]></category>
		<category><![CDATA[CDC]]></category>
		<category><![CDATA[cervical cancer]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[genital warts]]></category>
		<category><![CDATA[hpv vaccine]]></category>
		<category><![CDATA[Merck]]></category>
		<category><![CDATA[oropharyngeal cancer]]></category>
		<category><![CDATA[penile cancer]]></category>
		<category><![CDATA[vaginal cancer]]></category>
		<category><![CDATA[vulvar cancer]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11969</guid>
		<description><![CDATA[Source: HemOncToday.com The CDC&#8217;s Advisory Committee on Immunization Practices today approved routine recommendation in favor of administering the quadrivalent HPV vaccine for boys aged 11 to 12 years. Committee members decided that the vaccine (Gardasil, Merck) was safe, efficacious and cost-effective enough to warrant routine usage in this population. The recommendation issued in 2009 was [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/hpv-vaccine-recommended-for-boys-aged-11-to-12-years/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New HPV Study Proves Vaccine&#8217;s Effectiveness</title>
		<link>http://oralcancernews.org/wp/new-hpv-study-proves-vaccines-effectiveness/</link>
		<comments>http://oralcancernews.org/wp/new-hpv-study-proves-vaccines-effectiveness/#comments</comments>
		<pubDate>Tue, 27 Sep 2011 18:18:52 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[anal cancer]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[cervical cancer]]></category>
		<category><![CDATA[Food and Drug Administration]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[International Agency for Research on Cancer]]></category>
		<category><![CDATA[journal of the national cancer institute]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11846</guid>
		<description><![CDATA[Source: Cancer.gov A flurry of new research findings on a vaccine that prevents persistent infections by cancer-causing types of the human papillomavirus (HPV) has confirmed the vaccine&#8217;s efficacy and opened new avenues for research. The results, published in three separate reports, suggest that the vaccine could be simpler to administer and more affordable than researchers [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/new-hpv-study-proves-vaccines-effectiveness/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HPV Vaccine and Premarital-Sex Controversy</title>
		<link>http://oralcancernews.org/wp/hpv-vaccine-and-premarital-sex-controversy/</link>
		<comments>http://oralcancernews.org/wp/hpv-vaccine-and-premarital-sex-controversy/#comments</comments>
		<pubDate>Tue, 27 Sep 2011 17:32:53 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[cervical cancer]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[genital warts]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[hpv vaccine]]></category>
		<category><![CDATA[immune system]]></category>
		<category><![CDATA[oral cancer]]></category>
		<category><![CDATA[prostate cancer]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11843</guid>
		<description><![CDATA[Source: The News Tribune Some perspective is needed on the controversy over the Human Papillomavirus (HPV) vaccine that arose after a recent Republican presidential debate. The best way to do that is to take sex out of the equation. Instead of preventing a sexually transmitted disease that can lead to cervical cancer in women and [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/hpv-vaccine-and-premarital-sex-controversy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Screening For HPV Persistence And Cervical Cancer Risk</title>
		<link>http://oralcancernews.org/wp/screening-for-hpv-persistence-and-cervical-cancer-risk/</link>
		<comments>http://oralcancernews.org/wp/screening-for-hpv-persistence-and-cervical-cancer-risk/#comments</comments>
		<pubDate>Tue, 20 Sep 2011 18:00:40 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[cancer screenings]]></category>
		<category><![CDATA[cervical cancer]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[journal of the national cancer institute]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11820</guid>
		<description><![CDATA[Source: Medical News Today Women over the age of thirty who test positive for HPV (Human Papillomavirus) should be re-tested two years later as part of cervical cancer screening, according to a study published online TK in the Journal of the National Cancer Institute. HPV infection is the main cause of cervical cancer, although most [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/screening-for-hpv-persistence-and-cervical-cancer-risk/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

